GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,956,000 | +0.4% | 414,014 | +0.8% | 0.08% | +6.6% |
| Q1 2022 | $17,885,000 | +0.0% | 410,588 | +1.3% | 0.08% | +10.1% |
| Q4 2021 | $17,878,000 | +13.4% | 405,395 | -1.8% | 0.07% | +3.0% |
| Q3 2021 | $15,771,000 | +5.9% | 412,733 | +10.4% | 0.07% | +1.5% |
| Q2 2021 | $14,890,000 | +2.5% | 373,930 | -8.1% | 0.07% | -7.0% |
| Q1 2021 | $14,522,000 | +8.6% | 406,897 | +12.0% | 0.07% | +9.2% |
| Q4 2020 | $13,374,000 | -15.5% | 363,433 | -13.6% | 0.06% | -27.8% |
| Q3 2020 | $15,826,000 | -7.7% | 420,463 | -0.0% | 0.09% | -16.7% |
| Q2 2020 | $17,151,000 | +6.6% | 420,470 | -1.0% | 0.11% | -15.0% |
| Q1 2020 | $16,088,000 | -16.3% | 424,598 | +3.8% | 0.13% | +0.8% |
| Q4 2019 | $19,212,000 | +17.8% | 408,858 | +7.0% | 0.13% | +5.9% |
| Q3 2019 | $16,314,000 | +9.0% | 382,243 | +2.2% | 0.12% | +3.5% |
| Q2 2019 | $14,964,000 | -2.2% | 373,915 | +2.1% | 0.12% | -8.7% |
| Q1 2019 | $15,298,000 | +10.6% | 366,060 | +1.1% | 0.13% | -5.3% |
| Q4 2018 | $13,837,000 | -5.3% | 362,130 | -0.5% | 0.13% | +5.6% |
| Q3 2018 | $14,613,000 | +0.4% | 363,777 | +0.8% | 0.13% | -10.0% |
| Q2 2018 | $14,550,000 | +3.2% | 360,942 | +0.0% | 0.14% | -1.4% |
| Q1 2018 | $14,097,000 | +56.5% | 360,816 | +42.0% | 0.14% | +51.1% |
| Q4 2017 | $9,010,000 | -12.4% | 254,007 | +0.2% | 0.09% | -19.7% |
| Q3 2017 | $10,288,000 | -6.2% | 253,407 | -0.4% | 0.12% | -14.6% |
| Q2 2017 | $10,968,000 | +5.8% | 254,358 | +3.5% | 0.14% | -0.7% |
| Q1 2017 | $10,365,000 | +7.3% | 245,852 | -2.0% | 0.14% | -5.5% |
| Q4 2016 | $9,657,000 | +1.5% | 250,773 | +13.7% | 0.15% | -13.1% |
| Q3 2016 | $9,514,000 | +45.5% | 220,597 | +36.8% | 0.17% | -1.8% |
| Q1 2016 | $6,538,000 | +9.4% | 161,231 | +8.8% | 0.17% | +11.0% |
| Q4 2015 | $5,978,000 | +9.2% | 148,158 | +4.0% | 0.15% | -0.6% |
| Q3 2015 | $5,475,000 | -99.9% | 142,404 | -13.0% | 0.16% | +8.4% |
| Q2 2015 | $6,814,997,000 | +94948.8% | 163,625 | +5.3% | 0.14% | +6.7% |
| Q1 2015 | $7,170,000 | -99.9% | 155,370 | -1.6% | 0.13% | -0.7% |
| Q4 2014 | $6,749,300,000 | +5.5% | 157,915 | +13.5% | 0.14% | +1.5% |
| Q3 2014 | $6,397,715,000 | +39.7% | 139,172 | +62.5% | 0.13% | +33.0% |
| Q2 2014 | $4,579,317,000 | +20.8% | 85,627 | +20.7% | 0.10% | +8.7% |
| Q1 2014 | $3,791,630,000 | +7.7% | 70,964 | +7.6% | 0.09% | -1.1% |
| Q4 2013 | $3,520,771,000 | +14.7% | 65,944 | +7.8% | 0.09% | +1.1% |
| Q3 2013 | $3,070,278,000 | +105.1% | 61,197 | +104.3% | 0.09% | -41.0% |
| Q2 2013 | $1,496,901,000 | – | 29,956 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |